2011-10-21 16:18:28 cri
On October 21, the director of the State Food and Drug Administration Shao Mingli [in the picture] said that at the end of 2015, China will carry out electronic supervision on the production, circulation and use of all drugs sold on the market, on the occasion all drugs sold on the market will possess the "electronic ID card".
Shao Mingli said this on the same day during the China-ASEAN drug safety forum.
Electronic supervision of medicines is an important system in China aimed at controlling their quality during production and circulation. Once unwanted reactions occur, it will be possible to search in time where the drugs will end up in order to control their use, preventing counterfeit drugs from entering formal channels.
